In our study, we demonstrate that TNF-α and IL-1β also reprogram the metabolic landscape of pancreatic cancer cells, rendering their reliance on the de novo pyrimidine synthesis pathway. This evidence concerns the gene IL1B and familial pancreatic carcinoma.